COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

KRS Global Blog

12

August
2013

category:

503b Compounding

Torrent recalls anti-psychotic tablet from US market

http://articles.economictimes.indiatimes.com/2013-08-09/news/41240745_1_reversible-adverse-health-consequences-us-market-us-fda

read more

10

August
2013

category:

503b Compounding

Cancer Drug in Short Supply May Have Kept Woman Alive

http://www.nbcnewyork.com/investigations/cancer-drug-shortage-etoposide-219055881.html Another easy to make generic, this shouldn’t happen in the United States…

read more

10

August
2013

category:

503b Compounding

Two Amgen Plants Get 483s for Quality Violations

Amgen’s Longmont, Colo., and Boulder, Colo., facilities received Form 483s for observations that range from inadequate investigations into quality failures to no validation of manufacturing processes. Both facilities were inspected by the FDA in March. Investigators found at Longmont that Amgen personnel didn’t always follow up on certain quality issues. During the filling of a […]

read more